Search - tctmd.com

Displaying 221 - 240 of 677

Sort: Relevancy | Date

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

New-Onset AF Not Uncommon After Mitral TEER

Todd Neale

September 13, 2022

News Daily News

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

L.A. McKeown

September 09, 2022

News Daily News

Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis

L.A. McKeown

August 09, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

Presentation TVT 2022

Cardiovalve TMVR System; a Novel Treatment Option for Patients with Mitral Regurgitation (1 Recorded Case)

Presenter: Karl-Heinz Kuck

June 10, 2022

Presentation TVT 2022

Cardiovalve TMVR System; a Novel Technology for Patients with Mitral Regurgitation

Presenter: Francesco Maisano

June 10, 2022

Presentation TVT 2022

TEER and Annular Therapies: Outcomes and the Advances in Technology

Presenter: Scott Lim

June 09, 2022

Presentation TVT 2022

Outcomes of Transcatheter Mitral Valve Replacement Versus Edge-to-Edge Repair in Secondary Mitral Regurgitation Patients According to Adapted COAPT Inclusion Criteria

Presenter: Sebastian Ludwig

June 09, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

A CASE OF… Severe Functional Mitral Regurgitation in End-Stage HF: TEER as Bridge or Alternative to LVAD/Transplant

Presenter: Ulrich Jorde

June 09, 2022

Presentation TVT 2022

A Transseptal Approach to the Treatment of Mitral Regurgitation

Presenter: Scott Lim

June 08, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Opinion Editor's Corner EuroPCR 2022

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Shelley Wood

May 12, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

Advertisement

FDA Approves Pascal TEER Device for Degenerative MR

New-Onset AF Not Uncommon After Mitral TEER

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Minorities, Poorer Patients Missing Out on Structural Heart Care

Cardiovalve TMVR System; a Novel Treatment Option for Patients with Mitral Regurgitation (1 Recorded Case)

Cardiovalve TMVR System; a Novel Technology for Patients with Mitral Regurgitation

TEER and Annular Therapies: Outcomes and the Advances in Technology

Outcomes of Transcatheter Mitral Valve Replacement Versus Edge-to-Edge Repair in Secondary Mitral Regurgitation Patients According to Adapted COAPT Inclusion Criteria

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

A CASE OF… Severe Functional Mitral Regurgitation in End-Stage HF: TEER as Bridge or Alternative to LVAD/Transplant

A Transseptal Approach to the Treatment of Mitral Regurgitation

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content